Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine.

Suppr

超能文献

作者信息

McKerron C G, Scott R L, Asper S P, Levy R I

出版信息

J Clin Endocrinol Metab. 1969 Jul;29(7):957-61. doi: 10.1210/jcem-29-7-957.

DOI:10.1210/jcem-29-7-957

PMID:4978385

Abstract

摘要

相似文献

Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine.

J Clin Endocrinol Metab. 1969 Jul;29(7):957-61. doi: 10.1210/jcem-29-7-957.

Effect of clofibrate on serum thyroxine transport and free thyroxine levels.

Metabolism. 1969 Feb;18(2):141-7. doi: 10.1016/0026-0495(69)90108-5.

Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.实验性改变细胞中的微体。VI. 甲状腺素从血浆蛋白中的置换及氯贝丁酯的作用。

Arch Int Pharmacodyn Ther. 1969 Oct;181(2):386-93.

Influence of chlorophenoxyisobutyrate (CPIB) on thyroid parameters.

Acta Endocrinol (Copenh). 1969 Feb;60(2):294-302. doi: 10.1530/acta.0.0600294.

The effect of chlorphenoxyisobutyrate ('Atromid-S') on the biliary excretion and distribution of thyroxine in the rat.

Biochem Pharmacol. 1965 Oct;14(10):1479-81. doi: 10.1016/0006-2952(65)90181-4.

Effects of a new hypolipidemic agents, MK-185, on serum thyroxine-binding globulin (TBG) and dialyzable fraction thyroxine.新型降血脂药物MK-185对血清甲状腺素结合球蛋白（TBG）和可透析部分甲状腺素的影响。

J Clin Endocrinol Metab. 1972 Jan;34(1):200-8. doi: 10.1210/jcem-34-1-200.

Hypolipidemic, uricosuric, and thyroxine-displacing effects of MK-185 (halofenate).

Clin Pharmacol Ther. 1971 May-Jun;12(3):517-24. doi: 10.1002/cpt1971123517.

The effects of MK-185 on thyroid function.

Clin Pharmacol Ther. 1971 May-Jun;12(3):464-7. doi: 10.1002/cpt1971123464.

[A family with hereditary increase in thyroxine-binding globulin].[一个甲状腺素结合球蛋白遗传性增加的家族]

Dtsch Med Wochenschr. 1972 Feb 11;97(6):194-6. doi: 10.1055/s-0028-1107324.

Effects of ethyl chlorophenoxyisobutyrate on thyroxine distribution, transport and metabolism in man.

Metabolism. 1968 Oct;17(10):909-15. doi: 10.1016/0026-0495(68)90157-1.

引用本文的文献

L-T4 Therapy in the Presence of Pharmacological Interferents.L-T4 治疗中药物干扰的问题。

Front Endocrinol (Lausanne). 2020 Dec 22;11:607446. doi: 10.3389/fendo.2020.607446. eCollection 2020.

Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.甲状腺功能减退症治疗指南：由美国甲状腺协会甲状腺激素替代特别工作组制定。

Thyroid. 2014 Dec;24(12):1670-751. doi: 10.1089/thy.2014.0028.

Spurious t3 thyrotoxicosis unmasking multiple myeloma.假性T3甲状腺毒症掩盖多发性骨髓瘤

Case Rep Endocrinol. 2013;2013:739302. doi: 10.1155/2013/739302. Epub 2013 Jul 29.

Androgens, oestrogens, and coronary heart disease.雄激素、雌激素与冠心病

Br Med J (Clin Res Ed). 1981 Feb 7;282(6262):438-9. doi: 10.1136/bmj.282.6262.438.

Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.

Lipids. 1973 Jul;8(7):378-84. doi: 10.1007/BF02531712.

A review of studies on the mode of action of clofibrate and betabenzalbutyrate.氯贝丁酯和β-苄基丁酸酯作用模式的研究综述。

Lipids. 1972 Feb;7(2):106-9. doi: 10.1007/BF02532596.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验